Arakoda, the first antimalarial product approved by the Food and Drug Administration for the prevention of malaria, is being made available at select pharmacies and wholesalers.
Alnylam’s Givlaari has been approved by the FDA to treat a genetic disorder the causes buildup of toxic porphyrin molecules, which are formed during the production of heme.